Uromitexan is a drug used as a bladder prophylactic against the toxic effects of certain chemotherapy drugs, such as ifosfamide and cyclophosphamide. The drug works by neutralizing harmful substances that may pass from the kidneys and reach the bladder, preventing irritation and bleeding. This drug is given as an injection or tablet, and the timing of the dose is closely linked to the timing of chemotherapy to achieve maximum possible protection. Uromitexan does not interfere with the effectiveness of the primary treatment, but rather aims only to reduce its side effects on the urinary tract. Some mild symptoms may appear, such as headache or nausea, but these are usually temporary.
Uromitexan is considered an important drug for patients receiving chemotherapy that causes urinary complications.